What's happening
This bill establishes a fund to provide grants for patient access, education, and navigation services related to clinical trials in New York.
Why it matters
Reduces barriers to clinical trial participation. by funding transportation, lodging, and navigation services, making it easier for patients—especially those with life-threatening or disabling conditions—to access trials they might otherwise miss due to logistical or financial constraints.
Targets underserved and high-need populations. by prioritizing grants for organizations with proven experience helping patients with serious health conditions, potentially addressing disparities in clinical trial enrollment and access to cutting-edge treatments.
Enhances patient and provider awareness. through funded outreach and education, aiming to increase knowledge of clinical trial opportunities among patients, their families, and healthcare providers, which can lead to broader participation and more representative research results.
Accountability and transparency built in. by requiring annual reports from grantees on how funds are used and what impact they have, helping ensure public money is effectively supporting increased trial access and not being misallocated.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Fund Clinical Trial Access
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Fund Patient Clinical Trial Access
In Assembly Committee · Ways And Means · Sponsor Richard Gottfried
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
932
2019-2020 Regular Sessions
IN SENATE
January 9, 2019
Introduced by Sens. RIVERA, SEPULVEDA -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to establishing the clinical trial access and education fund
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2424 to read as follows:
§ 2424. Clinical trial access and education fund. 1. Definitions. For the purposes of this section, the following terms shall have the following meanings:
a. "Eligible applicant" means (i) a medical school that sponsors a clinical trial, (ii) a not-for-profit organization with experience and expertise working with patients with life-threatening or disabling conditions or diseases, (iii) a health care provider organization, association or society, (iv) a general hospital defined in article twentyeight of this chapter, (v) a county or city health department, or (vi) a municipality.
b. "Clinical trial" shall have the same meaning as in subdivision two-b of section forty-nine hundred of this chapter.
2. Establishment of fund. There is hereby established within the department a clinical trial access and education fund. Subject to appropriations, the department shall provide grants to eligible applicants on a competitive request for proposal basis to provide one or more of the following services to patients with life-threatening or disabling conditions or diseases, as such terms are defined in section forty-nine hundred of this chapter, to facilitate access to or education on clinical trials of treatments for the patient's condition or disease:
a. transportation services and lodging to provide patients with access to clinical trials or other related treatments while enrolled in a clin-
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03367-01-9
S. 932 2
ical trial or to access testing and other services to determine patient eligibility for a clinical trial;
b. patient outreach and education services to educate patients, their families and health care providers about the existence of and how patients may enroll in clinical trials, under section two hundred seven of this chapter; and
c. patient navigation services to help patients to determine if they are eligible for clinical trials, to help patients to enroll in clinical trials and to assist patients in dealing with insurance or other issues which serve as barriers to patient enrollment in clinical trials.
3. Applications. The commissioner shall establish an application process by which eligible applicants may apply for a grant under this section. The application shall include:
a. the geographic area in which the services shall be provided;
b. a detailed description of the services to be provided;
c. applicant's experience working with patients with life-threatening or disabling conditions or diseases;
d. applicant's ability to provide patient outreach or clinical trial education and navigation services, or coordinate or provide transportation and lodging for patients; and
e. any other information that the commissioner deems relevant and appropriate.
The commissioner shall give preference to eligible applicants who have experience and expertise working with patients with life-threatening or disabling conditions or diseases and providing patient outreach, education and health care navigation services.
4. Reports. Grantees shall file an annual report with the commissioner, in such form and with such information and data as the commissioner prescribes detailing the expenditure of grant funds and summarizing the efforts undertaken to increase patient access to clinical trials.
5. The commissioner shall make regulations reasonably necessary to implement the provisions of this section.
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to establishing the clinical trial access and education fund
Purpose or general idea of bill
This bill creates the Clinical Trial Access and Education Fund, a state grant program within the department to provide funding to address the major barriers to participation in clinical trials in New York State.
Summary of specific provisions
Section 1 amends article 24 of the public health law by adding a new section 2424, the Clinical Trial Access and Education Fund.
Read the full memo (647 words)
Subdivision 1 of the new section provides definitions of eligible appli- cant and clinical trial.
Subdivision 2 establishes the clinical trial access and education fund within the department to provide grants to eligible applicants on a competitive request for proposal basis to provide certain services to patients with life-threatening or disabling conditions or diseases. Such services would include: transportation and lodging to patients so they may access a clinical trial or related treatment; patient outreach and education on the existence of and how to enroll in clinical trials; and patient navigation services to help patients determine eligibility for clinical trials.
Subdivision 3 establishes an application process for eligible applicants and states that the commissioner shall give Preference to applicants who have experience and expertise providing patient outreach, education, navigation and other services to patients with life-threatening or disa- bling conditions or diseases.
Subdivision 4 requires grantees to file an annual report with the commissioner summarizing how they utilized the grant funds to increase patient access to clinical trials.
Subdivision 5 requires the commissioner to make any necessary regu- lations to implement the section.
Section 2 establishes the effective date.
Justification
New therapies to treat cancer and other life threatening diseases are being developed at an increasing pace. Clinical trials are the most effective, scientifically valid method of determining the benefits of experimental treatments. They are critical to improving health care and mortality rates for patients with cancer and other life-threatening diseases.
While fewer thanof adult cancer patients participate in clinical trials,of pediatric cancer patients do. This large number of pedia- tric enrollees has led to the discovery of groundbreaking therapies and a survival rate of over 80 for childhood cancer. To achieve a similar rate of success for adults with cancer and other diseases, information and access to clinical trials must be made more widely available to patients and their treating health care providers.,
A number of studies have looked at the reasons for low adult patient participation in clinical trials. One recent study conducted by the University of California Davis Cancer Center surveyed oncologists regarding patient and physician decision-making about participation in clinical trials. Of the 276 patients assessed, oncologists only recom- mended that 76 patients participate in clinical trials and only 39 patients or l4 actually enrolled in the trials. The two most common reasons that patients cited for declining to participate were a desire for other treatment and the distance from the cancer center. The study authors made a series of recommendations to overcome these barriers including the need for greater physician and patient education on the status, availability and benefits of clinical trials as well as the need to address geographical issues that serve as strong deterrents to clin- ical trial access.
The Clinical Trial Access and Education Fund will address these major barriers identified by the clinical research and anecdotally from patients and providers in New York, it will provide grants to non-for- profit community groups, health care provider associations and research centers that conduct clinical trials so they may provide and/ or facili- tate patient navigation, transportation, lodging and patient and provid- er education to achieve greater patient participation in clinical trials.
Prior legislative history
2014: S6442 2015-2016: 5777 2017-2018: 51216
Fiscal implications
None - subject to available appropriations.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.